Evidence of efficacy for relief of an array of symptoms is overall scanty, and almost all study participants are aged < 60 years. The risk of known and potential adverse effects is considerable, with concerns for cognitive, cardiovascular and gait and stability effects in older adults.
Cannabinoids for Mental Health: Large Review Finds Mostly Low-Quality Evidence With …
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Mental HealthEvidence QualitySystematic ReviewClinical Decision-MakingPatient Counseling Why This MattersThis systematic review highlights a persistent...